Results 81 to 90 of about 37,585 (155)
Serum sickness is an immune-complex-mediated illness that frequently occurs in patients after polyclonal antibody therapy (thymoglobulin). Although serum sickness has been described secondary to thymoglobulin therapy in adults, there are no reports in ...
Lucas da Silva, Paulo Sergio +7 more
core +1 more source
Introduction: During a period of local nonavailability of rabbit anti-thymocyte globulin (rATG) in India, anti-T-lymphocyte globulin (ATLG) was utilized in high-risk renal transplantation.
Shailendra Tiwari +4 more
doaj +1 more source
Early Application of Low Dose ATG to Prevent the Rejection After Corpse Renal Transplantation
Low dose antithymocyte globulin (ATG) was used to prevent the rejection in 436 patients with transplantation of kidney from the corpse.Results were that the rejection appeared in 72 patients (16.51%),blood creatinine returned to normal during 2 to 10 ...
叶桂荣
doaj
Guillain-Barre syndrome after antithymocyte globulin administration in a kidney transplant recipient: A case report and literature review. [PDF]
Tavakoli F +3 more
europepmc +1 more source
Acute pulmonary edema is a well-recognized complication after the first dose of OKT3 therapy in patients with fluid overload. The first-dose effect is thought to be related to the action of cytokines, namely tumor necrosis factor-alpha (TNF-α ...
Chan, TM, Cheng, IKP, Lo, WK, Lo, CY
core
Aim. To evaluate the efficacy of antithymocyte globulin (ATG) used in conditioning modes before allogeneic hemopoietic cell transplantation (allo-HCT) and its effect in reducing the incidence of posttransplantation complications.
Yu R Zalyalov +3 more
doaj
Background: Wound healing disorders are probably the most common post-transplantation surgical complications.It is thought that wound healing disturbance occurs due to antiproliferative effects of immunosuppressivedrugs.
G. R. Pourmand +6 more
doaj
Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia. [PDF]
Vieri M +7 more
europepmc +1 more source
The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study. [PDF]
Hong SY +6 more
europepmc +1 more source

